Download The Truveris Daily Recaps Of Asembia 2022
Day 1 Recap
On Day 1, we attended sessions on biosimilars, gene therapy, “inflationary rebates,” and tech-enabled patient access strategies.
See what we learned from these content tracks.Download Now
Day 2 Recap
Day 2 held the keynote address from Scott Gottlieb, former Commissioner of the FDA. Plus, Adam Fein dove into PBM revenue streams, new trends in pharmacy M&A, and how 340B is here to stay.
Read a summary of their presentations here.Download Now
Day 3 Recap
The focus of the final day at Asembia was around collaboration. How are new specialty drugs forcing pharmaceutical manufacturers to collaborate directly with employers? How are employers reacting?
Get our notes on Day 3 here.Download Now
What We Saw At Asembia 2022
We’ll See You At Next Year’s Asembia Conference.
To receive pharmacy news, insights, and updates all year long, subscribe to the Truveris email newsletter, Industry Pulse.Subscribe
Interested in learning more about how Truveris could help your pharmacy organization?
Contact us to speak with one of our pharmacy experts.